Biohaven Pharmaceutical raises $168 million in IPO – Yale Daily News (blog)

Biohaven Pharmaceutical raises $168 million in IPO
Yale Daily News (blog)
Biohaven Pharmaceutical, a clinical-stage biopharmaceutical company founded in 2014 by Yale School of Medicine researchers, raised $168 million in its initial public offering Thursday, pricing 9.9 million shares at $17 each. Based on Church Street inĀ …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd